Evidence map›Paper›PMID 34045524›Full record

ArticleScientific reports2021

Dynamic changes in gene-to-gene regulatory networks in response to SARS-CoV-2 infection.

Yoshihisa Tanaka, Kako Higashihara, Mai Adachi Nakazawa, Fumiyoshi Yamashita, Yoshinori Tamada, Yasushi Okuno

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Yoshihisa TanakaGraduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, 606-8507, Japan.
Kako HigashiharaGraduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan.
Mai Adachi NakazawaGraduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan.
Fumiyoshi YamashitaGraduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, 606-8507, Japan.
Yoshinori TamadaGraduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan. y.tamada@hirosaki-u.ac.jp.
Yasushi OkunoBiomedical Computational Intelligence Unit, HPC- and AI-driven Drug Development Platform Division, RIKEN Center for Computational Science, Kobe, 650-0047, Japan. okuno.yasushi.4c@kyoto-u.ac.jp.
Kyoto University · JPRIKEN Center for Computational Science · JPKyoto Pharmaceutical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current pandemic of SARS-CoV-2 has caused extensive damage to society. The characterization of SARS-CoV-2 profiles has been addressed by researchers globally with the aim of resolving this disruptive crisis. This investigation process is indispensable to understand how SARS-CoV-2 behaves in human host cells. However, little is known about the systematic molecular mechanisms involved in the effects of SARS-CoV-2 infection on human host cells. Here, we present gene-to-gene regulatory networks in response to SARS-CoV-2 using a Bayesian network. We examined the dynamic changes in the SARS-CoV-2-purturbated networks established by our proposed framework for gene network analysis, thus revealing that interferon signaling gradually switched to the subsequent inflammatory cytokine signaling cascades. Furthermore, we succeeded in capturing a COVID-19 patient-specific network in which transduction of these signals was concurrently induced. This enabled us to explore the local regulatory systems influenced by SARS-CoV-2 in host cells more precisely at an individual level. Our panel of network analyses has provided new insights into SARS-CoV-2 research from the perspective of cellular systems.

Indexed as

Gene Regulatory NetworksBayes TheoremCell LineComputational BiologyCOVID-19Databases, GeneticHumansRNA-SeqSARS-CoV-2Signal TransductionViral Load

Identifiers

PMID34045524
PMCPMC8160150
OpenAlexW3164535260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.